Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO)

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10285242" target="_blank" >RIV/00216208:11110/14:10285242 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/14:00080083 RIV/00209805:_____/14:#0000557 RIV/61989592:15110/14:33150318
Result on the web
<a href="http://dx.doi.org/10.1002/ijc.28835" target="_blank" >http://dx.doi.org/10.1002/ijc.28835</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ijc.28835" target="_blank" >10.1002/ijc.28835</a>

Result language
angličtina
Original language name
Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO)
Original language description
While the association between exposure to secondhand smoke and lung cancer risk is well established, few studies with sufficient power have examined the association by histological type. In this study, we evaluated the secondhand smoke-lung cancer relationship by histological type based on pooled data from 18 case-control studies in the International Lung Cancer Consortium (ILCCO), including 2,504 cases and 7,276 control who were never smokers and 10,184 cases and 7,176 controls who were ever smokers. We used multivariable logistic regression, adjusting for age, sex, race/ethnicity, smoking status, pack-years of smoking, and study. Among never smokers, the odds ratios (OR) comparing those ever exposed to secondhand smoke with those never exposed were 1.31 (95% Cl: 1.17-1.45) for all histological types combined, 1.26 (95% Cl: 1.10-1.44) for adenocarcinoma, 1.41 (95% Cl: 0.99-1.99) for squamous cell carcinoma, 1.48 (95% Cl: 0.89-2.45) for large cell lung cancer, and 3.09 (95% Cl: 1.62-5.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD branch
—

Project
<a href="/en/project/ED2.1.00%2F03.0101" target="_blank" >ED2.1.00/03.0101: Regional Centre for Applied Molecular Oncology (RECAMO)</a><br>
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)